Gelonghui on December 5 | Guizhou Bailing (002424.SZ) announced that recently, Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. received the “Notice of Approval of Supplemental Application for Drug Supplement” for chlorpheniramine maleate tablets approved and issued by the State Drug Administration. After review, the product passed the generic drug quality and efficacy consistency evaluation.
Chlorpheniramine maleate tablets are antihistamines used to treat allergic rhinitis, colds, sinusitis, and allergic skin diseases such as urticaria, allergic drug rash or eczema, angioedema, and itchy skin caused by insect bites.